ITRM20000688A0 - Uso della isovaleril l-carnitina per la preparazione di un medicamento per la prevenzione e cura dell'osteoporosi. - Google Patents

Uso della isovaleril l-carnitina per la preparazione di un medicamento per la prevenzione e cura dell'osteoporosi.

Info

Publication number
ITRM20000688A0
ITRM20000688A0 IT2000RM000688A ITRM20000688A ITRM20000688A0 IT RM20000688 A0 ITRM20000688 A0 IT RM20000688A0 IT 2000RM000688 A IT2000RM000688 A IT 2000RM000688A IT RM20000688 A ITRM20000688 A IT RM20000688A IT RM20000688 A0 ITRM20000688 A0 IT RM20000688A0
Authority
IT
Italy
Prior art keywords
isovaleril
carnitine
osteoporosis
medicines
prevention
Prior art date
Application number
IT2000RM000688A
Other languages
English (en)
Inventor
Aleardo Koverech
Alberta Zallone
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM20000688A0 publication Critical patent/ITRM20000688A0/it
Priority to IT2000RM000688A priority Critical patent/IT1317079B1/it
Priority to SK891-2003A priority patent/SK287306B6/sk
Priority to CA2434962A priority patent/CA2434962C/en
Priority to DE60112802T priority patent/DE60112802T2/de
Priority to HU0400735A priority patent/HU227342B1/hu
Priority to PL367293A priority patent/PL207879B1/pl
Priority to CZ2003-1890A priority patent/CZ304356B6/cs
Priority to PCT/IT2001/000614 priority patent/WO2002049639A1/en
Priority to AU2002217431A priority patent/AU2002217431A1/en
Priority to MXPA03006332A priority patent/MXPA03006332A/es
Priority to EP01271219A priority patent/EP1351676B1/en
Priority to AT01271219T priority patent/ATE301998T1/de
Priority to DK01271219T priority patent/DK1351676T3/da
Priority to US10/470,158 priority patent/US6906102B2/en
Priority to ES01271219T priority patent/ES2247005T3/es
Publication of ITRM20000688A1 publication Critical patent/ITRM20000688A1/it
Application granted granted Critical
Publication of IT1317079B1 publication Critical patent/IT1317079B1/it
Priority to US11/032,019 priority patent/US7084174B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT2000RM000688A 2000-12-21 2000-12-21 Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi. IT1317079B1 (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IT2000RM000688A IT1317079B1 (it) 2000-12-21 2000-12-21 Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi.
AU2002217431A AU2002217431A1 (en) 2000-12-21 2001-12-04 Use of isovaleryl l-carnitine for the preparation of a medicament for the prevention and cure of osteoporosis
EP01271219A EP1351676B1 (en) 2000-12-21 2001-12-04 Use of isovaleryl l-carnitine for the preparation of a medicament for the prevention and cure of osteoporosis
DE60112802T DE60112802T2 (de) 2000-12-21 2001-12-04 Verwendung von isovaleryl-l-carnitin zur herstellung eines arzneimittels zur vorbeugung und therapie von osteoporose
HU0400735A HU227342B1 (en) 2000-12-21 2001-12-04 Use of isovaleryl l-carnitine for the preparation of a medicament for the prevention and cure of osteoporosis
PL367293A PL207879B1 (pl) 2000-12-21 2001-12-04 Zastosowanie izowalerylo L-karnityny lub jej farmakologicznie dopuszczalnej soli do otrzymywania leku
CZ2003-1890A CZ304356B6 (cs) 2000-12-21 2001-12-04 Použití isovaleryl- L-karnitinu k přípravě léčiva k prevenci a léčbě zlomenin
PCT/IT2001/000614 WO2002049639A1 (en) 2000-12-21 2001-12-04 Use of isovaleryl l-carnitine for the preparation of a medicament for the prevention and cure of osteoporosis
SK891-2003A SK287306B6 (sk) 2000-12-21 2001-12-04 Použitie izovaleryl L-karnitínu na prípravu lieku na prevenciu a liečenie zlomenín
MXPA03006332A MXPA03006332A (es) 2000-12-21 2001-12-04 Uso de isovaleril-l-carnitina para preparacion de medicamento para prevencion y cura de fracturas.
CA2434962A CA2434962C (en) 2000-12-21 2001-12-04 Use of isovaleryl l-carnitine for the treatment of fractures
AT01271219T ATE301998T1 (de) 2000-12-21 2001-12-04 Verwendung von isovaleryl-l-carnitin zur herstellung eines arzneimittels zur vorbeugung und therapie von osteoporose
DK01271219T DK1351676T3 (da) 2000-12-21 2001-12-04 Anvendelse af isovaleryl-L-carnitin til fremstilling af et lægemiddel til forebyggelse og behandling af frakturer
US10/470,158 US6906102B2 (en) 2000-12-21 2001-12-04 Use of isovaleryl L-carnitine to increase healing of bone fractures
ES01271219T ES2247005T3 (es) 2000-12-21 2001-12-04 Uso de isovaleril l-carnitina para la preparacion de un medicamento para la prevencion y curacion de osteoporosis.
US11/032,019 US7084174B2 (en) 2000-12-21 2005-01-11 Administration of isovaleryl L-carnitine to stimulate osteoblastic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000688A IT1317079B1 (it) 2000-12-21 2000-12-21 Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi.

Publications (3)

Publication Number Publication Date
ITRM20000688A0 true ITRM20000688A0 (it) 2000-12-21
ITRM20000688A1 ITRM20000688A1 (it) 2002-06-21
IT1317079B1 IT1317079B1 (it) 2003-05-26

Family

ID=11455074

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000RM000688A IT1317079B1 (it) 2000-12-21 2000-12-21 Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi.

Country Status (15)

Country Link
US (2) US6906102B2 (it)
EP (1) EP1351676B1 (it)
AT (1) ATE301998T1 (it)
AU (1) AU2002217431A1 (it)
CA (1) CA2434962C (it)
CZ (1) CZ304356B6 (it)
DE (1) DE60112802T2 (it)
DK (1) DK1351676T3 (it)
ES (1) ES2247005T3 (it)
HU (1) HU227342B1 (it)
IT (1) IT1317079B1 (it)
MX (1) MXPA03006332A (it)
PL (1) PL207879B1 (it)
SK (1) SK287306B6 (it)
WO (1) WO2002049639A1 (it)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290801B1 (it) * 1996-07-05 1998-12-11 Mendes Srl Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili
IT1291141B1 (it) * 1997-04-16 1998-12-29 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente una alcanoil l-carnitina, atta a stimolare la moltiplicazione e la crescita degli osteoblasti
IT1299191B1 (it) 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa

Also Published As

Publication number Publication date
PL367293A1 (en) 2005-02-21
WO2002049639A1 (en) 2002-06-27
CA2434962A1 (en) 2002-06-27
CZ304356B6 (cs) 2014-03-26
ATE301998T1 (de) 2005-09-15
EP1351676B1 (en) 2005-08-17
SK8912003A3 (en) 2003-11-04
US6906102B2 (en) 2005-06-14
HU227342B1 (en) 2011-04-28
US20050143458A1 (en) 2005-06-30
CZ20031890A3 (cs) 2004-04-14
MXPA03006332A (es) 2004-04-21
US20040077718A1 (en) 2004-04-22
DE60112802D1 (de) 2005-09-22
IT1317079B1 (it) 2003-05-26
CA2434962C (en) 2010-02-09
ITRM20000688A1 (it) 2002-06-21
SK287306B6 (sk) 2010-06-07
DE60112802T2 (de) 2006-03-16
ES2247005T3 (es) 2006-03-01
HUP0400735A3 (en) 2009-01-28
AU2002217431A1 (en) 2002-07-01
PL207879B1 (pl) 2011-02-28
US7084174B2 (en) 2006-08-01
DK1351676T3 (da) 2005-12-19
HUP0400735A2 (hu) 2004-07-28
EP1351676A1 (en) 2003-10-15

Similar Documents

Publication Publication Date Title
ATE312602T1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
HK1047231A1 (en) Oral pharmaceutical forms of administration with adelayed action with tramadol
BR0213358A (pt) Uso de flibanserina
DK0754061T3 (da) Ny oral farmaceutisk doseringsform
HUP0400529A3 (en) Use of chlorpromazine and pentamidine for preparation of pharmaceutical compositions for the treatment of neoplastic disorders
WO2002000209A3 (en) Gabapentin analogues for sleep disorders
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
ATE432707T1 (de) Pharmazeutische zubereitung
EP1440691A3 (en) Treatment of neurotic disorders
NO20035602D0 (no) Sammensetning som omfatter en PDE-4-inhibitor og H1- reseptorantagonist, samt anvendelse derav til fremstilling av et medikament forbehandling av åndedrettsykdommer
ITRM20000340A0 (it) Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie cara
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
ITRM20000571A0 (it) Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni.
BR9911005A (pt) Uso de ozÈnio para a preparação de medicamentos para o tratamento de cáries dentárias
ITRM20000688A0 (it) Uso della isovaleril l-carnitina per la preparazione di un medicamento per la prevenzione e cura dell'osteoporosi.
IL152751A0 (en) Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
ITRM20010293A0 (it) Uso della acetil-l-carnetina per la preparazione di un medicamento per la prevenzione del dolore.
ITRM20000433A0 (it) Uso di fibrati per la preparazione di un medicamento utile nel trattamento dell'insufficenza cardiaca congestizia.
ITRM20010319A1 (it) Uso di una alcanoil l-carnitina per la preparazione di un medicamentoper il trattamento dell'anedonia.
ITRM20010292A1 (it) Uso dell'acetil l-carnitina per la preparazione di un medicamento peril trattamento dell'anedonia.
HUP0402118A3 (en) Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease
IT1318563B1 (it) Uso della n-acetilcisteina per la preparazione di composizionifarmaceutiche orali per il trattamento dell'asma.
ITRM990328A0 (it) Uso di l-carnitina fumarato nella preparazione di un medicamento utile nel trattamento dell'ischemia d'organo.
ITMI20010971A0 (it) Formulazioni farmaceutiche e/o dietetiche contenenti colostro e uso del colostro per il trattamento dell'acne